Cargando…
Acute interstitial nephritis related to immune checkpoint inhibitors
BACKGROUND: Immune checkpoint inhibitors (anti-PD1 or anti-CTLA-4) are increasingly used in various cancers. Immune checkpoint inhibitors (ICI)-related renal disorders are poorly described (9 cases) and were only related to Ipilimumab. METHODS: Retrospective collection of clinical charts of all the...
Autores principales: | Belliere, Julie, Meyer, Nicolas, Mazieres, Julien, Ollier, Sylvie, Boulinguez, Serge, Delas, Audrey, Ribes, David, Faguer, Stanislas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5155358/ https://www.ncbi.nlm.nih.gov/pubmed/27832664 http://dx.doi.org/10.1038/bjc.2016.358 |
Ejemplares similares
-
Renal Complications Related to Checkpoint Inhibitors: Diagnostic and Therapeutic Strategies
por: Belliere, Julie, et al.
Publicado: (2021) -
Membranous Nephropathy After Exposure to Immune Checkpoint Inhibitors
por: Benyahia, Rayane, et al.
Publicado: (2023) -
UMOD genetic variations and myeloma cast nephropathy
por: Belliere, Julie, et al.
Publicado: (2019) -
Immune checkpoint inhibitors and their interaction with proton pump inhibitors–related interstitial nephritis
por: Miao, Jing, et al.
Publicado: (2023) -
Hyperacute Onset of Immune Checkpoint Inhibitor–Related Acute Interstitial Nephritis
por: Tawhari, Ibrahim, et al.
Publicado: (2020)